Hormone replacement therapy (HRT) shortage: switching to Femoston® (estradiol/dydrogesterone) from an alternative combination oral or transdermal HRT
Information for healthcare professionals only.
This Guidelines supplement has been commissioned and funded by Mylan and developed in partnership with Guidelines. The content on page 3 was commissioned by Mylan and Mylan has carried out full medical review and approval to ensure compliance. See page 2 for full disclaimer.